Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Back
ePoster
P177
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
Peter J. Goadsby
London, GB
Joel M. Trugman
Madison, US
Appointment
Date:
06/12/2023
Time:
19:35
–
19:40
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
ePoster station 11
Poster
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
Session
ePoster 11
Topic
Aura and premonitory symptoms
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy